These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tiagabine: a novel drug with a GABAergic mechanism of action. Gram L Epilepsia; 1994; 35 Suppl 5():S85-7. PubMed ID: 8039478 [TBL] [Abstract][Full Text] [Related]
4. Tiagabine monotherapy in the treatment of partial epilepsy. Schachter SC Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789 [TBL] [Abstract][Full Text] [Related]
6. A review of the antiepileptic drug tiagabine. Schachter SC Clin Neuropharmacol; 1999; 22(6):312-7. PubMed ID: 10626090 [TBL] [Abstract][Full Text] [Related]
7. Use of new antiepileptic drugs in the treatment of childhood epilepsy. Pellock JM; Appleton R Epilepsia; 1999; 40 Suppl 6():S29-38; discussion S73-4. PubMed ID: 10530681 [TBL] [Abstract][Full Text] [Related]
9. Epilepsy in the elderly: the use of tiagabine. Pedersen B Epilepsia; 2001; 42 Suppl 3():52-4. PubMed ID: 11520325 [TBL] [Abstract][Full Text] [Related]
10. Update on the mechanism of action of antiepileptic drugs. Meldrum BS Epilepsia; 1996; 37 Suppl 6():S4-11. PubMed ID: 8941036 [TBL] [Abstract][Full Text] [Related]
11. New antiepileptic drugs: comparison of key clinical trials. Cramer JA; Fisher R; Ben-Menachem E; French J; Mattson RH Epilepsia; 1999 May; 40(5):590-600. PubMed ID: 10386528 [TBL] [Abstract][Full Text] [Related]
12. International experience with tiagabine add-on therapy. Ben-Menachem E Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788 [TBL] [Abstract][Full Text] [Related]
13. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy. Kälviäinen R J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435 [TBL] [Abstract][Full Text] [Related]
14. Treatment of paediatric epilepsy in Germany: antiepileptic drug utilisation in children and adolescents with a focus on new antiepileptic drugs. Dörks M; Langner I; Timmer A; Garbe E Epilepsy Res; 2013 Jan; 103(1):45-53. PubMed ID: 22795320 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of new antiepileptic drugs. Gram L Epilepsia; 1996; 37 Suppl 6():S12-6. PubMed ID: 8941037 [TBL] [Abstract][Full Text] [Related]
16. Role of new and established antiepileptic drugs. Leppik IE Epilepsia; 1998; 39 Suppl 5():2-6. PubMed ID: 9737436 [No Abstract] [Full Text] [Related]
17. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Adkins JC; Noble S Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548 [TBL] [Abstract][Full Text] [Related]
18. Basic mechanisms of gabitril (tiagabine) and future potential developments. Meldrum BS; Chapman AG Epilepsia; 1999; 40 Suppl 9():S2-6. PubMed ID: 10612355 [TBL] [Abstract][Full Text] [Related]